GUIDED THERAPEUTICS INC | Uncategorized | Business Contracts

Form of Warrants issued to Auctus Fund, LLC (Filed With SEC on September 15, 2022)

Agreement dated September 30, 2021, by and between Guided Therapeutics, Inc. and Richard P. Blumberg (Filed With SEC on March 30, 2022)

Amendment to the Agreement by and between Guided Therapeutics Inc. and Shandong Yaohua Medical Instrument Corporation, dated August 12, 2021 (Filed With SEC on September 7, 2021)

Form of Acknowledgement (Filed With SEC on June 10, 2021)

Finders Fee Agreement with JH Darbie, dated as of May 19, 2020 (Filed With SEC on April 7, 2021)

Finders Fee Agreement with FCMI, dated as of June 11, 2020 (Filed With SEC on April 7, 2021)

Finders Fee Agreement, dated as of January 6, 2020, by and between Guided Therapeutics, Inc. and Iron Stone Capital (Filed With SEC on April 20, 2020)

Form of Exchange Agreement (Filed With SEC on September 6, 2018)

Equity Financing Agreement dated March 1, 2018 by and between the Company and GHS Investments LLC (Filed With SEC on June 14, 2018)

Form of Registration Rights Agreement dated March 8, 2018 by and between the Company and GHS Investments LLC (Filed With SEC on June 14, 2018)

CONVERTIBLE PROMISSORY NOTE (Filed With SEC on November 13, 2017)

SECURITIES PURCHASE AGREEMENT (Filed With SEC on November 13, 2017)

SECURITIES PURCHASE AGREEMENT (Filed With SEC on October 25, 2017)

CONVERTIBLE PROMISSORYNOTE (Filed With SEC on August 24, 2017)

SECURITIES PURCHASE AGREEMENT (Filed With SEC on August 24, 2017)

Forbearance Agreement, dated August 8, 2017, between the Company and GPB Debt Holdings II LLC (Filed With SEC on August 17, 2017)

UNITED STATES SECURITIES AND EXCHANGECOMMISSION Washington, D.C.20549 FORM 8-K CURRENTREPORT Pursuant toSection 13 or 15(d) of the Securities ExchangeAct of 1934 Date of... (Filed With SEC on August 14, 2017)

COMMON STOCK PURCHASE WARRANT Guided Therapeutics, Inc. (Filed With SEC on June 7, 2017)

SECURITIES PURCHASE AGREEMENT (Filed With SEC on June 7, 2017)

PLACEMENT AGENCY AGREEMENT June __, 2017 (Filed With SEC on June 7, 2017)

GUIDEDTHERAPEUTICS, INC. 8%CONVERTIBLE REDEEMABLE NOTE DUEMAY 17, 2018 (Filed With SEC on May 24, 2017)

GUIDEDTHERAPEUTICS, INC. 8%CONVERTIBLE REDEEMABLE NOTE DUEMAY 17, 2018 BACKEND NOTE (Filed With SEC on May 24, 2017)

GUIDEDTHERAPEUTICS, INC. 8%CONVERTIBLE REDEEMABLE NOTE DUEMAY 17, 2018 (Filed With SEC on May 24, 2017)

GUIDEDTHERAPEUTICS, INC. 8%CONVERTIBLE REDEEMABLE NOTE DUEMAY 17, 2018 BACKEND NOTE (Filed With SEC on May 24, 2017)

SECURITIESPURCHASE AGREEMENT (Filed With SEC on May 24, 2017)

ADARBAYS, LLC COLLATERALIZEDSECURED PROMISSORY NOTE (Filed With SEC on May 24, 2017)

SECURITIESPURCHASE AGREEMENT (Filed With SEC on May 24, 2017)

[remainderof page intentionally left blank] (Filed With SEC on March 30, 2017)

Agreement, dated January 22, 2017, between the Company and Shandong Yaohua Medical Instrument Corporation (Filed With SEC on March 24, 2017)

CONVERTIBLEPROMISSORY NOTE (Filed With SEC on February 17, 2017)

COMMONSTOCK PURCHASE WARRANT GUIDEDTHERAPEUTICS, INC. (Filed With SEC on February 17, 2017)

SECURITIESPURCHASE AGREEMENT (Filed With SEC on February 17, 2017)

Agreement, dated January 22, 2017, between the Company and Shandong Yaohua Medical Instrument Corporation (Filed With SEC on January 26, 2017)

Agreement, dated January 22, 2017, between the Company and Shenghuo Medical, LLC (Filed With SEC on January 26, 2017)

10% OID Convertible Promissory Note (Filed With SEC on December 30, 2016)

Securities Purchase Agreement, dated December 28, 2016, between the Company and RedDiamond (Filed With SEC on December 30, 2016)

FORM OF NOTE (Filed With SEC on December 7, 2016)

GUIDED THERAPEUTICS INC (247) | Uncategorized (143)